These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 1539243
21. Late liver function with graft obtained from donors above 65 years. Regueira FM, Diez-Caballero A, Herrero I, Rotellar F, Hernández Lizoáin JL, Quiroga J, Pardo F, Cienfuegos JA. Transplant Proc; 2002 Feb; 34(1):231-2. PubMed ID: 11959259 [No Abstract] [Full Text] [Related]
22. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients. Conti F, Dousset B, Cherruau B, Guérin C, Soubrane O, Houssin D, Calmus Y. Clin Transplant; 2004 Jun; 18(3):235-41. PubMed ID: 15142042 [Abstract] [Full Text] [Related]
23. The use of the lidocaine-monoethylglycinexylidide test in the liver transplant recipient. Potter JM, Hickman PE, Henderson A, Balderson GA, Lynch SV, Strong RW. Ther Drug Monit; 1996 Aug; 18(4):383-7. PubMed ID: 8857555 [Abstract] [Full Text] [Related]
24. Relationship of apolipoproteins AI, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post-transplant period. Armstrong VW, Schütz E, Kaltefleiter M, Luy M, Helmhold M, Wieland E, Ringe B, Oellerich M. Eur J Clin Invest; 1995 Jul; 25(7):485-93. PubMed ID: 7556366 [Abstract] [Full Text] [Related]
25. Importance of early arterialization of the liver graft. Rasmussen A, Palfelt I, Larsen PN, Hjortrup A, Kirkegaard P. Transplant Proc; 1994 Jun; 26(3):1790. PubMed ID: 8030137 [No Abstract] [Full Text] [Related]
26. Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability. Fairchild R, Solomon H, Contis J, Kaminski D. Arch Surg; 1996 Oct; 131(10):1099-102. PubMed ID: 8857911 [Abstract] [Full Text] [Related]
27. Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients. Schroeder TJ, Gremse DA, Mansour ME, Theuerling AW, Brunson ME, Ryckman FC, Suchy FJ, Penn I, Alexander JW, Pesce AJ. Transplant Proc; 1989 Feb; 21(1 Pt 2):2299-301. PubMed ID: 2652744 [No Abstract] [Full Text] [Related]
28. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients. Tchervenkov JI, Tector AJ, Cantarovich M, Tahta SA, Asfar A, Naimi J, Elias N, Barkun J. Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214 [No Abstract] [Full Text] [Related]
30. Results of partial liver transplantation in Finland. Höckerstedt K, Leijala M, Isoniemi H, Sairanen H, Salmela K. Transplant Proc; 1994 Jun; 26(3):1782-3. PubMed ID: 8030132 [No Abstract] [Full Text] [Related]
31. Donor hyaluronic acid and MEGX levels do not accurately predict posttransplant liver function. Michell ID, Abdulnour I, Pzybylowski G, Bowkett J, Gleeson A, Hardy KJ, Jones RM. Transplant Proc; 1993 Oct; 25(5):2888-9. PubMed ID: 8212275 [No Abstract] [Full Text] [Related]
32. Preliminary assessment of glycine conjugation of para-aminobenzoic acid as a quantitative test of liver function. Duffy LF, Kerzner B, Seeff L, Barr SB, Soldin SJ. Clin Biochem; 1995 Oct; 28(5):527-30. PubMed ID: 8582052 [Abstract] [Full Text] [Related]
33. Combined liver-kidney transplantation from a living-related donor. Haberal M, Abbasoğlu O, Büyükpamukçu N, Bilgin N, Telatar H, Simşek H, Cuhadaroğlu S, Velidedeoğlu E, Uzunalimoğlu B, Kayhan B. Transplant Proc; 1993 Jun; 25(3):2211-3. PubMed ID: 8516873 [No Abstract] [Full Text] [Related]
34. Combined procurement of liver and pancreas does not influence early graft function and survival. Kim SC, Lee SG, Han DJ, Lee YJ, Kwon TW, Park KM, Choi BW, Min PC. Transplant Proc; 1996 Jun; 28(3):1882-4. PubMed ID: 8658929 [No Abstract] [Full Text] [Related]
35. A comparison of University of Wisconsin and albumin solutions for donor liver preservation. Mears DC, Sheil AG, Kelly GE, Dilworth P, Ishikawa T. Transplant Proc; 1992 Feb; 24(1):260-2. PubMed ID: 1539274 [No Abstract] [Full Text] [Related]
36. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors. Zotz RB, von Schönfeld J, Erhard J, Breuer N, Lange R, Beste M, Goebell H, Eigler FW. Transplantation; 1997 Feb 27; 63(4):538-41. PubMed ID: 9047147 [Abstract] [Full Text] [Related]
37. Evaluation of hepatic excretory system function by determination of serum bile acid clearance early after liver transplantation. Kohlhaw K, Canello R, Ringe B, Hauss J, Schumann G, Oellerich M, Pichlmayr R. Transplant Proc; 1992 Dec 27; 24(6):2699-700. PubMed ID: 1465905 [No Abstract] [Full Text] [Related]
38. Extrahepatic production of the lignocaine metabolite monoethylglycinexylidide (MEGX). Sallie RW, Tredger JM, Williams R. Biopharm Drug Dispos; 1992 Oct 27; 13(7):555-8. PubMed ID: 1489946 [Abstract] [Full Text] [Related]
39. Donor rating in human liver transplantation: correlation of oxygen consumption after revascularization with MEGX formation in donors. Burdelski M, Oellerich M, Bornscheuer A, Luebbe N, Ringe B, Lamesch P, Raude E, Raith H, Scheruhn M, Gubernatis G. Transplant Proc; 1989 Feb 27; 21(1 Pt 2):2392-3. PubMed ID: 2652779 [No Abstract] [Full Text] [Related]
40. Reliability of the MEGX test in the selection of liver grafts. Adam R, Azoulay D, Astarcioglu I, Bao YM, Bonhomme L, Fredj G, Bismuth H. Transplant Proc; 1991 Oct 27; 23(5):2470-1. PubMed ID: 1926438 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]